CINCINNATI--(BUSINESS WIRE)--Procter & Gamble’s (NYSE: PG) Vicks VapoRub, the brand families have relied on for over a century, is excited to announce that NFL quarterback Drew Brees will be the brand’s first-ever “VapoDad.” For the first time in over 100 years, a father-figure will appear as the primary caregiver in its advertisements. Appearing alongside his real-life son Baylen, Brees will be seen in television and print advertisements for VapoRub this upcoming cold and flu season.
Historically, VapoRub has only featured women as the primary caregiver in its advertisements. With fathers becoming increasingly involved in the upbringing of their children, Vicks felt it was important now more than ever to feature its first VapoDad.
“Vicks believes that both mothers and fathers play an equally important role in the health of the family unit,” says Andy Cipra, Brand Manager, Vicks North America. “Drew Brees is known for his close relationship with his family, which made the decision to make Brees the first VapoDad a natural one.”
Drew Brees first worked with the brand with advertisements for Vicks DayQuil® and NyQuil®. The VapoRub spots will differ by providing a more family-focused message, highlighting the nurturing role parents play in their children’s lives.
“I’m truly honored to become the first-ever Vicks VapoDad. My son Baylen and I had the opportunity to shoot this commercial together, which makes this opportunity that more special for me,” says Drew Brees. “There are no sick days in the Brees household, so when Baylen comes down with a cold, we use VapoRub to provide relief for his cough and cold symptoms.”
Vicks VapoRub is over 100 years old with one of the most recognizable scents in the world. Research has shown that the therapeutic vapors found in VapoRub can help provide the feeling of freer breathing to a person suffering from a cough due to the common cold1. Simply rub Vicks VapoRub on the chest and throat to temporarily relieve coughs due to common colds or on muscles and joints to temporarily relieve minor aches and pains. The combination of vapors in Vicks VapoRub, including menthol, camphor and Eucalyptus Oil, works to reduce a cough by acting on airway sensory nerves.2, 3
Vicks VapoRub is indicated for adults and children two years of age and older.
For more information about Vicks VapoRub and the new VapoDad advertisements, please go to www.Facebook.com/VicksVapoRubUS.
About Vicks®
One of the most recognized brands around the world. Available in more than 70 countries and on 5 continents, Vicks has helped relieve cough, cold, and flu symptoms for generations. In the US the Vicks family includes, NyQuil®, the #1 pharmacist recommended brand for Adult Cold Nighttime Relief4, NyQuil® Sinex®, Children’s NyQuil®, DayQuil® Cold/Flu LiquiCaps, DayQuil® Cold/Flu, DayQuil® Cough, DayQuil® Sinex®, VapoRub® Ointment, VapoRub® Cream, BabyRub®, Vicks® Formula 44® Custom Care™ Chesty Cough, Vicks® Formula 44 Custom Care™ Dry Cough, Vicks® Formula 44® Custom Care™ Cough & Cold PM , Sinex® 12 Hour Spray, Sinex® Ultra Fine Mist, Sinex® 12 Hour Ultra Fine Mist Moisturizing, Vicks® VapoDrops®. Headquartered in Cincinnati, OH, Vicks is owned and distributed by Procter & Gamble.
About Procter & Gamble
P&G touches and improves the lives of about 4.4 billion people around the world with its portfolio of trusted, quality brands. The Company's leadership brands include Pampers®, Tide®, Ariel®, Always®, Whisper®, Pantene®, Mach3®, Bounty®, Dawn®, Fairy®, Gain®, Pringles®, Charmin®, Downy®, Lenor®, Iams®, Crest®, Oral-B®, Duracell®, Olay®, Head & Shoulders®, Wella®, Gillette®, Braun®, Fusion®, Ace®, Febreze®, and Ambi Pur®. With operations in about 80 countries, P&G brands are available in more than 180 countries worldwide. Please visit http://www.pg.com for the latest news and in-depth information about P&G and its brands.
1 Procter & Gamble (2011). The Science Behind VapoRub. The Power of Touch and Therapeutic Vapors
2 Eccles R. “Over the counter medicines for colds” in Common Cold.
3 Birkhauser Verlag 2008 and Handbook for Non-prescription Drugs section IV Respirator Disorders 2009. NOTE
4 Survey conducted by Pharmacy Times, OTC Supplement, Adult Cold-Nighttime, June 2009
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50051173&lang=en